XFI Corporation
Edward Broenniman has a diverse work experience spanning several industries. Edward began their career in 1977 as the Managing Director at The Piedmont Group LLC. In 1992, they joined Aethlon Medical, Inc. as the Director and eventually took on additional responsibilities as the Chair of the Compensation Committee and Audit Committee. Broenniman also served as a Director at XFI Corporation in 2005. From 2006 to 2012, they held the role of Director, Executive Vice President, and CFO at Consumer Health Advisers, Inc. Broenniman was also a Director at Pechan Associates, Inc. from 2005 to 2012. In addition, they served as the Chair and Director at the National Association of Corporate Directors, Capital Area Chapter from 1990 to 2012. Lastly, they held the roles of Entrepreneur in Residence and Director at the Dingman Center, University of Maryland from 1990 to 2005.
Edward Broenniman has a Master of Business Administration (MBA) degree from Stanford University Graduate School of Business, where they focused on Finance and Marketing. Edward also holds a Bachelor of Arts degree in Economics from Yale University. No specific dates are provided for their education history.
This person is not in any teams
XFI Corporation
XFI’s primary focus has been developing technology for the delivery of novel diagnostics and therapeutics in critical healthcare fields such as oncology. Starting in 2015, XFI shifted its focus from business-to-business to patient-direct solutions, currently code-named Zatient™. Zatient is an AI-based healthcare application for use by patients, families, and healthcare practitioners. Zatient applies XFI’s knowledge and experiences over the past 20 years to patient decision-making. Zatient will deliver clear, unbiased information relevant to the patient’s specific condition and sensitive to the patient’s and family’s personal value system and preferences. Zatient will guide, inspire, and enable patients to better understand and participate in high-quality healthcare decisions.